-
ACCL1333
A study designed to evaluate the safety and efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in children with newly diagnosed Acute Lympho.
Type: Treatment
Principal Investigator: Richard Drachtman, MD
Trial is open for enrollment
For inquiries, call
(732) 235-8861
-
ACURATE
Evaluation of the safety and efficacy of the Acurate valve for transcatheter aortic valve replacement (TAVR)
Type: Device trial
Principal Investigator: Mark Russo, MD
Trial is open for enrollment
For inquiries, call (732) 235-9215
-
AEGIS II
A phase 3, multi-center, double-blind, randomized, placebo-controlled, parallel-group study designed to investigate the efficacy and safety of CSL 112 (Apolipoprotein A-I: human) on reducing the risk of major adverse CV events in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI), including those managed with percutaneous coronary intervention (PCI) or medically managed.
Type: Treatment
Trial is open for enrollment
View All Details
For inquiries, call
(908) 864-4027
-
ALIGN-AR
To evaluate the safety and effectiveness/performance of the Transfemoral JenaValve Pericardial TAVR System in the treatment of patients with symptomatic severe aortic regurgitation.
Type: Device trial
Principal Investigator: Mark Russo, MD
Trial is open for enrollment
For inquiries, call (732) 235-9215
-
ALIGN-AS
To evaluate the safety and effectiveness/performance of the Transfemoral JenaValve Pericardial TAVR System in the treatment of patients with symptomatic severe aortic stenosis.
Type: Device trial
Principal Investigator: Mark Russo, MD
Trial is open for enrollment
For inquiries, call (732) 235-9215
-
AMULET
A study designed to evaluate the safety and effectiveness of the AMPLATZER Amulet Left Atrial Appendage Occluder.
Type: Device trial
Trial is not open for enrollment
For inquiries, call
(973) 926-6938
-
ARRAY 797-301
A phase 3, multinational, randomized, placebo-controlled study of ARRY-371797 in patients with symptomatic dilated cardiomyopathy due to a lamin A/C gene mutation.
Type: Drug trial
Principal Investigator: Saurabh Kapoor, MD
Trial isĀ open for enrollment
For inquiries, call
(973) 926-8451
-
ASAP-TOO
The purpose of this study is to establish the safety and effectiveness of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device, including the post-implant medication regimen, for subjects with non-valvular atrial fibrillation who are deemed not to be eligible for anti-coagulation therapy to reduce the risk of stroke.
Type: Device trial
Principal Investigator: David Dobesh, MD
Trial is open for enrollment
For inquiries, call
(973) 736-6333
-
CIRT
A randomized clinical trial investigating whether taking low-dose methotrexate
reduces heart attacks, strokes, or death in people with type 2 diabetes
or metabolic syndrome that have had a heart attack or multiple coronary
blockages.
Type: Drug trial
Principal Investigator: John B. Kostis, MD
Trial is open for enrollment
For inquiries, call
(732) 235-6546
-
CLASP II TR
A study designed to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with tricuspid regurgitation.
Principal Investigator: Mark Russo, MD
Type: Device
This trial is open for enrollment
For inquiries, call
(732) 235-9215
-
CLASP IID & IIF
Evaluation of the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCAL Transcatheter Valve Repair System compared to Abbott MitraClip in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)
Type: Device trial
Principal Investigator: Mark Russo, MD
Trial is open for enrollment
For inquiries, call (732) 235-9215
-
COMPASSION XT PAS
Evaluation of the longer-term safety and effectiveness of the SAPIEN XT transcatheter heart valve (THV) in the pulmonic position for the intended patient population (especially pediatric) when used as indicated with all valve sizes.
Type: Device trial
Principal Investigator: Marc Cohen, MD and Rajiv Verma, MD
Trial is not open for enrollment
For inquiries, call
(973) 926-8451